Kimberly-Clark Corporation (NYSE:KMB) reported its fourth-quarter 2024 earnings, showcasing a minor miss on earnings per share (EPS) but exceeding revenue expectations. The company's EPS came in at $1 ...
Maze Therapeutics (NASDAQ:MAZE) shares were trading largely flat following a $140M initial public offering. Shares of the kidney disease drug developer opened at $16 per share after being priced at ...
Stay updated on the latest earnings reports in the communication services sector, including Meta Platforms, AT&T, and ...